3 results
The main objective of this Phase IIa/b study is to demonstrate the effectof zibotentan on HVPG, and that dapagliflozin can mitigate fluid retention safety concernsregarding its use in this population.
Single-pulse TMS will be applied across the primary motor cortex to address corticospinal pathways, resulting in a response in the electromyographic signal of the target muscles. The primary objective of the experiment described by this amendment is…
To determine whether dapagliflozin is superior to placebo in reducing the incidence of the primary composite endpoint of kidney failure, hospitalization for heart failure, and all-cause mortality in the overall patient group, consisting of patients…